Fachbeirat des Instituts

Um die hohe Qualität der wissenschaftlichen Forschung zu gewährleisten, werden alle Institute der Max-Planck-Gesellschaft regelmäßig von unabhängigen Fachbeiräten begutachtet. Deren Mitglieder sind Experten von weltweit führenden Forschungseinrichtungen und Universitäten. Der Max-Planck-Präsident ernennt die Mitglieder auf der Basis von Vorschlägen des Instituts. Sie werden für eine Amtszeit von maximal sechs Jahren berufen.

Unser Fachbeirat umfasst die folgenden 26 Mitglieder:

• Prof. Dr. Julie Ahringer, 
  Wellcome Trust/Cancer Research UK Gurdon Institute, Cambridge, UK
• Prof. Dr. David W. Chandler,
  Sandia National Laboratories, California, USA
• Prof. Dr. Francesca Ciccarelli,
  Cancer Systems Biology Laboratory, The Francis Crick Institute, London, UK
• Prof. Dr. Graeme Davis,
  Department of Biochemistry and Biophysics, University of California, San Francisco, USA
• Prof. Dr. Kristina Djinovic Carugo,
  European Molecular Biology Laboratory (EMBL), Grenoble, France
• Prof. Dr. Lucio Frydman,
  Department of Chemical and Biological Physics, Weizmann Institute of Science, Rehovot, Israel
• Prof. Dr. Yukiko Goda, 
  Okinawa Institute of Science and Technology Graduate University, Okinawa, Japan
• Prof. Dr. Angela Gronenborn,
  Department of Structural Biology, University of Pittsburgh, Pennsylvania, USA
• Prof. Dr. Rebecca W. Heald,
  Department of Molecular & Cell Biology, University of California, Berkeley, USA
• Prof. Dr. Johan Hofkens,
  Molecular Imaging and Photonics, KU Leuven, Leuven, Belgium
• Prof. Dr. Laurinda Jaffe,
  School of Medicine, University of Connecticut, Connecticut, USA
• Prof. Dr. Franz X. Kärtner,
  Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
• Prof. Dr. Ute Kaiser,
  Electron Microscopy Group of Materials Science, Ulm University, Ulm, Germany
• Prof. Dr. Katrin Karbstein,
  Department of Biochemistry, Karbstein Lab, Vanderbilt University, Tennessee, USA
• Prof. Dr. Kinneret Keren,
  Physics Department, Technion – Israel Institute of Technology, Haifa, Israel
• Prof. Dr. Rob Klose,
  Department of Biochemistry, Oxford University, Oxford, UK
• Prof. Dr. Iain Mattaj, (CHAIR)
  Fondazione Human Technopole, Milan, Italy
• Prof. Dr. Steven McKnight,
  Department of Biochemistry, UT Southwestern Medical Center, Texas, USA
• Prof. Dr. Daniel M. Neumark,
  College of Chemistry, University of California, Berkeley, USA
• Prof. Dr. Arthur G. Palmer III,
  Department of Biochemistry and Molecular Biophysics, Columbia University, New York, USA
• Prof. Dr. Tatyana Polenova,
  Department of Chemistry and Biochemistry, University of Delaware, Delaware, USA
• Prof. Dr. Anna Marie Pyle,
  Dept. of Molecular, Cellular and Developmental Biology, Dept. of Chemistry, Yale University, Connecticut, USA
• Prof. Dr. Jeremy C. Smith, 
  Oak Ridge National Laboratory, Tennessee, USA
• Prof. Dr. Beth Stevens,
  Harvard Medical School, Boston Children’s Hospital, Massachusetts, USA
• Prof. Dr. Peter Tielemann,
  Department of Biological Sciences, Biocomputing Group, University of Calgary, Calgary, Canada
• Prof. Dr. Joachim Wittbrodt,
  Centre for Organismal Studies, Heidelberg University, Heidelberg, Germany